Skip Navigation

Neonatology Research

Several neonatology faculty are involved in research programs covering basic, translational and clinical research.  Basic research includes studies in vascular physiology and intestinal development.  Translational research includes animal models of bowel function and growth after bowel resection. Current clinical studies are described below:   

Downey Laura Corbin
L. Corbin Downey, MD, MPH 

Antibiotic Safety in Infants with Complicated Intra-Abdominal Infections (SCAMP)
Principle Investigator: L. Corbin Downey, MD, MPH 
Coordinator: TB A 
Study Type: Randomized, multi-center, open-label, safety study 
Purpose: Assess the safety and efficacy of various antibiotic regiments in infants with complicated intra-abdominal infections. 

Preterm Erythropoietin Neuroprotection Trial (PENUT)
Principle Investigator:  L. Corbin Downey, MD, MPH 
Coordinator: Lanier 
Study Type: Randomized, multi-center trial 
Purpose: To test the hypothesis that early high dose erythropoietin decreases the risk of brain damage in extremely preterm infants.

Helderman Jennifer B
Jennifer B. Helderman, MD, MS

Neonatal Neurobehavioral: Does it Predict Developmental Outcome at 2 Years of Age (NOVI)
Principal Investigator: Jennifer B. Helderman, MD, MS
Co-Investigator:  Michael O'Shea, MD, MPH 

Coordinator: Lanier
Study Type: multi-centered observational
Purpose: To test the hypothesis that an abnormal neurobehavioral examination at 36 weeks post-menstrual age is predictive of adverse  outcome at 2 years of age. 

 Porcelli Jr Peter J
Peter J. Porcelli, MD, MS 

Infant Bacterial Therapeutics - (IBT)
Principle Investigator: Peter J. Porcelli, MD, MS 
Coordinator: Lanier  
Study Type: Randomized, double blind, parallel-group, dose escalation placebo controlled multicenter study to investigate the safety and tolerability of IBP-9414 administered in preterm infant.  

Washburn Lisa K
Lisa K. Washburn, MD

PEPC-2 (Prenatal Events - Postnatal Consequences)                        
Prinicipal Investigator
: Lisa K. Washburn, MD
Coordinator: Scott
Funding: NIH
Study Type: Observational Cohort
Purpose: This is a study of cardiovascular metabolic outcomes of 19 year old children

ELGAN-2  (Neonatal Biomarkers in Extremely Preterm Babies Predict Childhood Brain Disorders (Extremely Low Gestational Age Newborns-2) -(began October 2011) 
Principal Investigator: Lisa K. Washburn, MD
Co-Investigator: T. Michael O'Shea, MD, MPH 
Coordinator: TBA
Funding: NIH
Study Type: Observational; multi-centered; NIH 
Purpose: To evaluate the relationship of perinatal inflammation and cognitive impairment in extremely preterm children. 









Quick Reference


Fax 336-716-2525

8 am - 5 pm
Find A Doctor Ways to Give
Last Updated: 07-13-2016
Wake Forest Baptist Ranked among Nation’s ‘Best Hospitals’  25 Years in a Row by U.S. News & World ReportComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.